Oncology & Hematology Coding Alert
Reader Question:
Cystoscopic Surveillance Does Not Guide Your Bladder Cancer Reporting
Published on Thu Feb 28, 2019
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
Related Articles
Other Articles in this issue of
Oncology & Hematology Coding Alert
- Hematology:
Here's How to Collect the Clotting Factor Pay You Deserve
You’ll need to make a distinction between acquired and congenital hemophilia A. Do you find [...] - CMS:
CERT Report Says 3.0 Percent of Oncology / Hematology Visits Were Paid Improperly
Hint: Zero in on your oncology radiation therapy claims. Your oncology practice is probably active [...] - Incident-To:
Follow This Expert Advice for Smart 'Incident to' Billing
Identify NPP services, describe direct supervision, and check payer guidelines. ‘Incident to’ billing is nearly [...] - You Be the Coder:
Malignant Bladder Tumor
Question: Our oncologist treated a patient for suspected bladder cancer. The diagnosis documented was ‘adherent, [...] - Reader Question:
Cystoscopic Surveillance Does Not Guide Your Bladder Cancer Reporting
Question: Please provide directions for reporting ‘history of bladder cancer’ versus ‘bladder tumor of unspecified [...] - Reader Question:
Choose Your Scope Code Based on Examined Area
Question: If the oncologist inserts a scope through the nose to examine the larynx, is [...]
View All
